Sigyn Therapeutics (SIGY) EPS (Basic) Growth (3y) (2020 - 2025)
Analysis
Sigyn Therapeutics (SIGY) EPS (Basic) Growth (3y) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.16 Bn | 175.56 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 127.68 Bn | 122.46 Bn | 1.96 Bn | 24.18% |
| 3 | Medtronic | 117.10 Bn | 108.28 Bn | 6.34 Bn | 24.57% |
| 4 | Stryker | 104.81 Bn | 101.33 Bn | 4.50 Bn | 19.63% |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 50.64% |
| 6 | Edwards Lifesciences | 49.94 Bn | 45.69 Bn | 1.35 Bn | -6.23% |
| 7 | Alcon | 33.07 Bn | 31.61 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.37 Bn | 30.42 Bn | 830.00 Mn | 29.56% |
| 9 | Steris | 20.77 Bn | 20.28 Bn | 684.20 Mn | 17.98% |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | -164.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -164.47% |
| Jun 30, 2025 | -269.86% |
| Mar 31, 2025 | -184.00% |
| Dec 31, 2024 | -126.61% |
| Sep 30, 2024 | -273.30% |
| Jun 30, 2024 | -239.02% |
| Mar 31, 2024 | -260.97% |
| Dec 31, 2023 | -159.04% |
| Sep 30, 2023 | 64.65% |
| Jun 30, 2023 | -82.16% |
| Mar 31, 2023 | -128.67% |
| Dec 31, 2022 | -963.93% |
| Sep 30, 2022 | -125.22% |
| Jun 30, 2022 | -131.64% |
| Mar 31, 2022 | -208.58% |
| Dec 31, 2021 | -21.71% |
| Sep 30, 2021 | -49.40% |
| Jun 30, 2021 | -53.26% |
| Mar 31, 2021 | -0.75% |
| Dec 31, 2020 | -55.61% |